SignalXSignalX

SOLV Solventum

8-K Current Report
Filed: February 26, 2026
Health Care
Surgical & Medical Instruments & Apparatus
Solventum Overview

Solventum (SOLV) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 or full-year earnings release filed Feb 26, 2026 — refer to attached exhibit for key financial figures
  • • Signed by VP/Associate General Counsel Rice, indicating routine authorized filing

Get deeper insights on Solventum

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.